USE OF VONICOG ALFA: REPORTS OF PREGNANCIES OUTCOME IN TWO PATIENTS WITH TYPE 2 VON WILLEBRAND DISEASES (2VWD)

被引：0
|
作者：
Schell, B. [1 ]
Desprez, D. [2 ]
Sattler, L. [3 ]
de Raucourt, E. [4 ]
Flaujac, C. [1 ]
机构：
[1] Hop Andre Mignot Versailles, Sect Hemostase, Lab Biol Med, Le Chesnay, France
[2] Ctr Ressources & Competences Malad Hemorrag, Le Chesnay, France
[3] Ctr Hosp Reg Univ Strasbourg, Lab Hematol, Strasbourg, France
[4] Hop Andre Mignot Versailles, Ctr Ressources & Competences Malad Hemorrag, Le Chesnay, France
来源：
HAEMOPHILIA | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P215
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [41] Abnormal angiogenesis in type 2A and 2B von willebrand disease (VWD): comparative studies of quantitative and qualitative VWD using blood outgrowth endothelial cells
    Casey, L.
    Bowman, M. L.
    Selvam, S. N.
    James, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 102 - 102
  • [42] Homozygous and heterozygous expression of type 2a von willebrand disease (VWD) variants: negative impact on mechanisms critical for von willebrand factor (VWF) processing and secretion
    Jacobi, P. M.
    Gill, J. C.
    Friedman, K. D.
    Montgomery, R. R.
    Haberichter, S. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 68 - 69
  • [43] Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients
    Baronciani, Luciano
    Peyvandi, Flora
    Punzo, Margherita
    Canciani, Maria T.
    Di Stasio, Enrico
    Federici, Augusto B.
    Mannucci, Pier M.
    De Cristofaro, Raimondo
    BLOOD, 2008, 112 (11) : 1161 - 1161
  • [44] Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2
    Menache, D
    HAEMOPHILIA, 1998, 4 : 44 - 47
  • [45] Relevance of chloride binding to von Willebrand factor in type 2B von Willebrand disease patients
    Baronciani, L.
    Peyvandi, F.
    Punzo, M.
    Lancellotti, S.
    Canciani, M. T.
    Federici, A. B.
    De Cristofaro, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (02) : 416 - 418
  • [46] A pregnant woman with von Willebrand disease (VWD) type 2b: Laboratory findings and peripartal bleeding management
    Holstein, K.
    Spath, B.
    Greinacher, A.
    Budde, U.
    Bokemeyer, C.
    Schneppenheim, R.
    Langer, F.
    HAEMOPHILIA, 2012, 18 : 196 - 196
  • [47] Identification of two closely located new type 2N 2vWD mutations (Tyr32Cys and Met37Val)
    Hilbert, L
    Ruan, C
    Jorieux, S
    Fontenay-Roupie, M
    Stieljes, N
    Lavergne, JM
    Frissenaud, E
    Meyer, D
    Mazurier, C
    THROMBOSIS AND HAEMOSTASIS, 1999, : 281 - 282
  • [48] Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease
    Baronciani, L.
    Federici, A. B.
    Cozzi, G.
    Canciani, M. T.
    Mannucci, P. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (02) : 282 - 288
  • [49] Molecular analysis of type 2 von Willebrand disease in Iranian patients
    Soteh, M. Hashemi
    Jazebi, M.
    Ravanbod, S.
    Enayat, S.
    Rastegar-lari, G.
    Ala, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1146 - 1147
  • [50] Molecular characterisation and discrimination of patients with Type 2 Von Willebrand disease
    Jenkins, V. P.
    Byrne, M. B.
    Keenan, C.
    Holden, F.
    Nolan, B.
    O'Connell, N.
    O'Donnell, J. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 677 - 678
12345